about
Single agent versus combination chemotherapy for metastatic breast cancerRisk of recurrence, subsequent mode of birth and morbidity for women who experienced severe perineal trauma in a first birth in New South Wales between 2000-2008: a population based data linkage study.Trends and risk factors for severe perineal trauma during childbirth in New South Wales between 2000 and 2008: a population-based data study.Birthplace in New South Wales, Australia: an analysis of perinatal outcomes using routinely collected data.Menopausal hormone therapy is associated with having high blood pressure in postmenopausal women: observational cohort studyPostpartum hypertension and nonsteroidal analgesia.Obstetric and psychosocial risk factors for Australian-born and non-Australian born women and associated pregnancy and birth outcomes: a population based cohort studyRates of obstetric intervention among low-risk women giving birth in private and public hospitals in NSW: a population-based descriptive studyRole of proteinuria in defining pre-eclampsia: clinical outcomes for women and babies.Benchmarking and patient safety in hypertensive disorders of pregnancy.Severe perineal trauma is rising, but let us not overreact.Hypertension in pregnancy and long-term cardiovascular mortality: a retrospective cohort study.Benchmarking the Hypertensive Disorders of Pregnancy.A longitudinal analysis of angiotensin II type 1 receptor antibody and angiogenic markers in pregnancy.Urinary placental growth factor differentiates the hypertensive disorders of pregnancy.Maternal deaths in NSW (2000-2006) from nonmedical causes (suicide and trauma) in the first year following birth.Does the anti-hypertensive drug clonidine affect the short-term variation in CTG recordings?Exogenous soluble VEGF receptor-1 (sFlt-1) regulates Th1/Th2 cytokine production from normal placental explants via intracellular calcium.Reply: To PMID 23467048.Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro.The incidence of preeclampsia and eclampsia and associated maternal mortality in Australia from population-linked datasets: 2000-2008.Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1.Glucocorticoids inhibit placental cytokines from cultured normal and preeclamptic placental explants.Physical activity in pregnancy: women's perceptions, practices, and influencing factors.A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the PIVOT trial.Time poor: rushing decreases the accuracy and reliability of blood pressure measurement technique in pregnancy.Antihypertensive drugs clonidine, diazoxide, hydralazine and furosemide regulate the production of cytokines by placentas and peripheral blood mononuclear cells in normal pregnancy.The effect of medical and operative birth interventions on child health outcomes in the first 28 days and up to 5 years of age: A linked data population-based cohort study.Acute Pulmonary Oedema as a Complication of Hypertension During PregnancySoluble Flt-1 as a diagnostic marker of pre-eclampsiaAnti-Hypertensive Drugs Alter Cytokine Production from Preeclamptic Placentas and Peripheral Blood Mononuclear CellsGarlic increases IL-10 and inhibits TNFα and IL-6 production in endotoxin-stimulated human placental explantsGeneric obstetric database systems are unreliable for reporting the hypertensive disorders of pregnancyLow selenium is associated with the occurrence of preeclampsia in women from the United KingdomMaternal and perinatal outcomes by planned place of birth in Australia 2000 - 2012: a linked population data study
P50
Q24241459-FE9A7FAA-5706-45D8-9D43-89CD4F03396DQ30613306-6228078B-480B-46F7-83BF-D54D480D7BFEQ30651152-80B89A41-40F1-461F-A293-F388816E8C4FQ30831104-1BC4299E-85EF-4527-BC15-4956F46B6830Q34341907-2B047FC3-85B3-4180-89E7-748C3B78063BQ35674486-3BB60518-9624-4243-8685-D17590C57D09Q35836351-0B303D6D-4E32-48A0-84B5-66902B089618Q36307000-280B150E-9FCC-47F9-A24C-7CFB7A838A85Q37636515-C397ADFC-4D0A-4FF4-8006-CB5D27C844BDQ37884780-596AB92D-5130-4084-9C71-A72BB24BC5EBQ38273767-229BB20F-9A2B-4B75-8AC3-3DFCA1A7A1D3Q38923667-7473FA4B-581B-4E58-83DC-EBBDADB695B3Q39112968-6840665C-DF5F-4921-9807-62DBEC281678Q39237073-194F8421-586E-485F-8EBA-8228E076D0B2Q39996993-9FB0CE0E-A98F-4DEB-B8CE-B641CEAA7B7BQ42581242-93E0FB47-ABA9-4850-BF00-3BCD4383A5F7Q42840492-6535819D-0DFF-4C92-B300-6C0C9306F3EDQ43258256-6A6AF1C3-89E9-41BD-AB08-D8D5E9C870B5Q44044321-90C39857-143F-42F0-8AC8-C31F6E30FB30Q46122933-4A316C23-DE19-4089-87A9-969CD01BB763Q46320697-B0C82F37-8FE0-4B0D-8508-E94AF3B56681Q46339760-183232E3-4FCD-40A6-B1A8-5E7B5DBC6D88Q46638629-75AFC84C-C7E8-42D6-9ED0-1D09213BFD4AQ48188277-28AB516D-A04A-46B7-B113-96F716850E97Q48583641-0ED996E9-33A0-4EA4-AD74-E1497A77BD3AQ51156081-D2676CA0-70F1-4085-A45F-303416200609Q51226968-B0AE77EF-597B-4F0A-8528-3F6BCB7CAE40Q52632217-47D0677F-EDE3-4AB2-9279-44A7AE4A8539Q58623863-C52DE0C8-7C0D-4700-9FF1-B87FD5B7671DQ62504254-62DD5E3E-87D9-4235-B3F1-DDA6F3FF1FBEQ62504332-139FAB75-B16F-4930-A0AD-4596E8E548CAQ62504429-74061BBD-9A3E-403C-BE2F-80B287F306D0Q62504475-8B6162DC-BD1B-4AD6-96F1-A5D681800940Q62504483-56E4A586-DB42-477C-9D47-604713318CC1Q90990268-BF4503EA-A0A2-44A6-B80C-60D5CEF36D0B
P50
description
researcher ORCID ID = 0000-0003-4457-1799
@en
name
Charlene Thornton
@ast
Charlene Thornton
@en
Charlene Thornton
@es
Charlene Thornton
@nl
type
label
Charlene Thornton
@ast
Charlene Thornton
@en
Charlene Thornton
@es
Charlene Thornton
@nl
prefLabel
Charlene Thornton
@ast
Charlene Thornton
@en
Charlene Thornton
@es
Charlene Thornton
@nl
P21
P31
P496
0000-0003-4457-1799